Overview
Myocarditis caused by drugs, including macrolide antibiotics like midecamycin acetate (miokamycin), involves inflammation of the myocardium often linked to direct toxic effects or hypersensitivity reactions. 1Diagnosis
Clinical presentation includes chest pain, arrhythmias, and signs of heart failure.
Electrocardiogram (ECG) may show nonspecific changes or conduction abnormalities.
Cardiac biomarkers (troponin) are often elevated.
Echocardiography can reveal wall motion abnormalities.
Endomyocardial biopsy is definitive but rarely performed due to invasiveness.
Differential diagnosis should rule out other causes of myocarditis. 1Management
Discontinue the offending drug immediately upon suspicion.
Supportive care includes hemodynamic monitoring and management of heart failure symptoms.
Anti-arrhythmic therapy may be necessary for arrhythmias, tailored to specific arrhythmias identified.
Corticosteroids might be considered in severe cases with suspected hypersensitivity reactions, though evidence is limited. 1Special Populations
Pregnancy: Limited data; risk-benefit assessment crucial; avoid if possible unless essential. 1
Pediatrics: Similar principles apply; careful monitoring of drug dosing and toxicity is essential. 1
Elderly: Increased susceptibility to drug toxicity; close monitoring of cardiac function and drug effects is advised. 1
Comorbidities: Patients with pre-existing cardiac conditions may experience exacerbated symptoms; individualized management required. 1Key Recommendations
Discontinue the suspected drug immediately upon diagnosis of myocarditis to prevent further myocardial damage. (Evidence: Expert opinion) 1
Initiate supportive care measures including hemodynamic support and management of heart failure symptoms. (Evidence: Expert opinion) 1
Consider corticosteroids in severe cases with hypersensitivity reactions, though evidence is weak and individualized decision-making is advised. (Evidence: Weak) 1References
1 Yokota M, Takeda U, Odaki M, Sasaki H, Kawaoto H, Watanabe H et al.. Toxicological studies on a new macrolide antibiotic, midecamycin acetate (miokamycin). Part I-2. Acute toxicity in rats. The Japanese journal of antibiotics 1984. link